CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-31 | Snow Ellen SVP, CFO and Treasurer | Grant or award · Stock Option (Right to buy) | +224,000 | 224,000 | ||
| 2024-01-31 | Hadas Nicole R. SVP, Chief Legal Officer | Grant or award | +149,300 | 676,644 | ||
| 2024-01-31 | Hadas Nicole R. SVP, Chief Legal Officer | Grant or award · Stock Option (Right to buy) | +224,000 | 224,000 | ||
| 2024-01-31 | Butler John P. CEO and President | Grant or award | +603,500 | 2,175,372 | ||
| 2024-01-31 | Butler John P. CEO and President | Grant or award · Stock Option (Right to buy) | +905,200 | 905,200 | ||
| 2024-01-31 | Burke Steven Keith SVP, Chief Medical Officer | Grant or award | +202,200 | 735,687 | ||
| 2024-01-31 | Burke Steven Keith SVP, Chief Medical Officer | Grant or award · Stock Option (Right to buy) | +303,300 | 303,300 | ||
| 2023-08-25 | Burke Steven Keith SVP, Chief Medical Officer | Sale | −27,000 | $1.15 | $31K | 668,840 |
| 2023-07-31 | Snow Ellen SVP, CFO and Treasurer | Grant or award | +370,000 | 370,000 | ||
| 2023-07-31 | Snow Ellen SVP, CFO and Treasurer | Grant or award · Stock Option (Right to buy) | +560,000 | 560,000 | ||
| 2023-06-06 | ZUMWALT LEANNE M Director | Grant or award | +30,000 | 43,700 | ||
| 2023-06-06 | ZUMWALT LEANNE M Director | Grant or award · Stock Option (Right to buy) | +45,000 | 45,000 | ||
| 2023-06-06 | ROGERS MICHAEL W Director | Grant or award | +30,000 | 96,029 | ||
| 2023-06-06 | ROGERS MICHAEL W Director | Grant or award · Stock Option (Right to buy) | +45,000 | 45,000 | ||
| 2023-06-06 | FRIESON RON Director | Grant or award | +30,000 | 43,700 | ||
| 2023-06-06 | FRIESON RON Director | Grant or award · Stock Option (Right to buy) | +45,000 | 45,000 | ||
| 2023-06-06 | Wolf Myles Director | Grant or award | +30,000 | 67,681 | ||
| 2023-06-06 | Wolf Myles Director | Grant or award · Stock Option (Right to buy) | +45,000 | 45,000 | ||
| 2023-06-06 | ADAMS ADRIAN Director | Grant or award | +30,000 | 134,800 | ||
| 2023-06-06 | ADAMS ADRIAN Director | Grant or award · Stock Option (Right to buy) | +45,000 | 45,000 |
Page 7 of 21 · 405 trades